Life Sciences – Page 6 – WA Innovation Calendar

Maximising your chances for grant success with CRC-P Round 19

MTPConnect invites you to a practical webinar designed to help you build competitive Cooperative Research Centres-Projects (CRC-P) applications, delivered through our WA Life Sciences Innovation Hub (WALSIH), Adelaide Intermediary Program (AIP) and Industry Growth Program (IGP) service.

This webinar is available exclusively to companies and innovators based in SA and WA, and/or IGP clients.

What you’ll gain

A clear overview of CRC-P program objectives, eligibility and partnerships
What assessors value and how to evidence impact, feasibility, and collaboration
Common mistakes and practical ways to address them
A real-world case study from a successful CRC-P recipient
Live Q&A

WA Spotlight on Biomedical Careers: Talent, Transition & Transformation

Discover biomedical career pathways in WA. Employer insights, real journeys and networking across research, industry and government.

Ready to discover what a career in WA’s biomedical sector really looks like?

The ‘WA Spotlight on Biomedical Careers: Talent, Transition, Transformation’ is an exciting in-person event exploring current and emerging workforce opportunities across WA’s growing biomedical sector. The sector extends well beyond traditional clinical and health roles and includes opportunities in research, advanced manufacturing, product development, digital and data, clinical trials, government and start-ups.

This event brings together employers, recruiters, government and sector leaders to provide practical insights into career pathways, hiring expectations and skills needed now and into the future.

Whether you are a student, researcher or industry professional considering a career transition, the session will help you better understand where your skills fit and how to take the next step.

GreenTech Hub Summer Sundowner

Since its launch in August 2025, the WA GreenTech Hub has been driving innovation, building connections and supporting the transition to a cleaner, more sustainable future for Western Australia.

Now, let’s take some time to celebrate! Come and join us on Wednesday 25 February from 4 to 7 PM for a relaxed late-afternoon sundowner where we’ll celebrate our achievements, share what’s next in energy transitions and bring together stakeholders, industry partners and the wider community, while enjoying drinks, light refreshments and lively conversations in a welcoming and informal setting.

Don’t miss out, this is your chance to connect, reflect and imagine the future together!

We’re looking forward to having you there!

2026 Perth Biodesign Flagship Program Info Session

Thinking about applying for the Perth Biodesign 2026 Flagship program? Wondering if it’s right for you?

You’ll learn all about the program structure, what’s involved, how past cohorts went, tips for the application process and the time commitment. You’ll also hear from Biodesign alumni about their experience!

Bright Minds, Bold Voices: Reimagining how we fly

Bright Minds, Bold Voices: Reimagining how we fly

Project Sunrise is Qantas’ bold leap into the future of ultra-long-haul travel, backed by evidence-based research by scientists at the Charles Perkins Centre, University of Sydney.

This bold project has transformed fundamental discoveries about circadian biology into real-life impact – reimagining in-flight lighting, movement, nutrition and sleep to reduce jet lag and improve travellers’ wellbeing with scientifically measurable benefits.

Their research has informed the design of next-generation aircraft, built with futuristic cabin features helping passengers arrive more rested, alert, and ready to go.

In conversation with ABC Canberra’s Lish Fejer, we’ll hear from two leaders of the project:

Vanessa Hudson is Qantas Group CEO and Managing Director. She is leading the airline towards Project Sunrise take-off, with the first flights scheduled for 2027.
Professor Stephen Simpson AC FAA FRS is leading the team of researchers from Charles Perkins Centre, using real-world passenger data to enhance the in-flight experience and inform the next generation of specially designed ultra-long-range aircraft.

This event is for everyone including students, professionals, academics, policymakers, lifelong learners, and those simply curious about how science is shaping our future.

“Solving the wicked problem of the gap from research to translation”- Dr. Noel Chambers, CEO, National Foundation for Medical Research and Innovation

Learn about NFMRI’s strategy, grants and processes. With a focus on supporting translation across the ‘valley of death’, NFMRI CEO, Dr. Noel Chambers will explain how research applicants can increase their chances of success when applying for NFMRI support.

This is an interactive presentation which explores current philanthropic giving/culture and expectations. It will address early translational research pathways, gaps and how NFMRI’s strategy supports preclinical research to become attractive and competitive when seeking next-step partners that can bring your innovations to communities in need.

DEADLINE: AusBiotech Investor Readiness Panel (IRP) EOIs

AusBiotech is proud to announce the establishment of its new Investor Readiness Panel (IRP).

The IRP will provide stage-appropriate, non-binding guidance on a company’s readiness to engage with investors.

Individuals with experience engaging life sciences companies across stages can apply, including:

Founders or CEOs of life sciences companies
Translational, clinical, or scientific experts
Commercialisation, licensing, or scale-up professionals
Investors (VC, CVC, family office, angel)

Successful applicants will demonstrate:

Ability to assess readiness to engage investors (not investment quality)
Comfort providing clear, written feedback asynchronously
Understanding (and able to help define) stage-appropriate investor engagement
Alignment with ’s non-endorsement, discovery-safe principles
Capacity to review submissions within agreed timeframes

Your contributions will be invaluable in shaping the direction and future investment progress that support the Australian ecosystem and AusBiotech.

An evening with John Van Der Wielen, FHRI Fund Advisory Council Chair

The WA Life Sciences Innovation Hub is delivering an exciting Spotlight event in February featuring John Van Der Wielen, Future Health Research and Innovation (FHRI) Fund Advisory Council Chair. The FHRI Fund is a major WA Government initiative, backed by sovereign wealth, to fund health and medical research, innovation, and commercialisation.

Join John and our Director Stakeholder Engagement Dr Tracey Wilkinson as they discuss the Fund’s new strategy, new programs (including the Spotlight program focused on rheumatic heart disease), reflections on the first four years of the Fund and what success looks like for the next four years.

Learn more and register here: An evening with John Van Der Wielen, FHRI Fund Advisory Council Chair

Innovative engineering in practice across health and energy

This full-day event showcases how innovative engineering is being applied across diverse sectors, from healthcare and advanced manufacturing to energy infrastructure.

The morning sessions focus on bioengineering, highlighting the critical role biomedical and clinical engineers play in patient care within Western Australia’s public health system. Through real-world case studies, presenters will demonstrate how advanced design, analysis and rehabilitation technologies are improving clinical outcomes, supporting surgeons and care teams, and enabling patients with complex needs to return meaningfully to the community.

By attending this presentation, attendees will:

understand how bioengineering and rehabilitation technologies are applied in clinical environments to improve patient care and outcomes
recognise the role of additive manufacturing as a complementary tool in modern manufacturing, enabling new design and production opportunities
gain insight into transmission line planning and infrastructure developments required to support increasing renewable energy penetration in Western Australia
appreciate how technological advances have transformed anaesthesia practice, highlighting the intersection of engineering, physics and healthcare.

From Vision to Approval: Building the Right Regulatory & Clinical Evidence

Join the Respiradigm team with guest speaker Hugo LeMessurier for a candid & insightful discussion on regulatory & clinical trials strategy.

In this panel, Respiradigm will share what the team is building and why a robust regulatory and clinical trials strategy is non‑negotiable if you want to move fast without costly missteps.

Expect a candid discussion focused on clarity, sequencing, and capital efficiency, so the next steps are the right steps.